AROMASIN is indicated for adjuvant treatment of postmenopausal women with estrogen-receptor constructive early breast cancer who may have acquired two to a few a long time of tamoxifen and are switched to AROMASIN for completion of a total of five consecutive yrs of adjuvant hormonal therapy [see Scientific Reports (14.1)].Suggest ladies of reprodu